RGN-6024

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameRGN-6024

Drug Alias NameRGN6024RGN-6024

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMicrotubule proteins inhibitors

TargetsMicrotubule proteins

Therapy Area/IndicationsBrain metastases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesReglagene Inc

China Registration ClassN/A

Active CompaniesReglagene Inc

Inactive CompaniesN/A

Active IndicationsBrain metastases

Inactive IndicationsN/A

ATC CodeN/A